[Redding, California] - Meticulous Research®, a premier global market intelligence firm renowned for its comprehensive analyses, has released its latest report titled "Infusion Pumps Market by Type (Volumetric, Syringe, Insulin, Ambulatory [Disposable, Chemo], Implantable), Channel (Single, Multi), Application (Oncology, Pain, Diabetes, Hematology, Pediatrics), End User (Hospital, Ambulatory Care) - Global Forecast to 2030."

According to this pioneering study, the infusion pumps market is poised for remarkable growth, projected to soar to $25.9 billion by 2030, registering a commendable CAGR of 8.3% during the forecast period. This expansion is propelled by several factors, including escalating demand for ambulatory infusion pumps, the escalating incidence of chronic diseases, the rapid aging of the population, a surge in surgical procedures, and heightened awareness of home healthcare solutions. However, challenges such as recurrent product recalls, increased adoption of refurbished and rental infusion pumps, and stringent regulatory requirements pose constraints to market advancement.

Moreover, the report identifies burgeoning opportunities within emerging markets and the rising adoption of specialty infusion systems, such as IoT infusion pumps. Nonetheless, challenges like the increasing incidence of medication errors and the absence of wireless connectivity in hospitals present obstacles to market growth.

Key Market Players

Leading players operating in the infusion pumps market include Becton, Dickinson and Company (BD), B. Braun SE (Germany), Baxter International Inc. (U.S.), Fresenius SE&Co. KGaA. (Germany), ICU Medical, Inc. (U.S.), Medtronic plc (Ireland), MOOG Inc. (U.S.), Terumo Corporation (Japan), F. Hoffmann-LA Roche Ltd (Switzerland), and Insulet Corporation (U.S.).

Infusion Pumps Market: Future Outlook

The infusion pumps market is meticulously segmented by Product Type [Devices (By Type {Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Ambulatory Infusion Pumps {Disposable Infusion Pumps and Chemotherapy Infusion Pumps}, Enteral Infusion Pumps, PCA Infusion Pumps, Implantable Infusion Pumps}, Devices by Mode {Manual Infusion Pumps, Automatic Infusion Pumps}), Infusion Pump Accessories/Consumables], Channel [Single Channel Infusion Pumps, Multi-Channel Infusion Pumps], Application [Diabetes Management, Oncology, Pain Management, Hematology, Neonatology/Pediatrics, Gastroenterology] End User [Hospitals & Clinics, Home Health Care, Academic & Research Institutes, Ambulatory Care Settings, and Nursing Homes], and Geography. Additionally, the study evaluates industry competitors and conducts comprehensive market analyses at both regional and country levels.

In 2023, the infusion pump accessories/consumables segment is anticipated to command the largest share of the infusion pumps market. This dominance is fueled by factors such as the rising utilization of infusion pumps in ambulatory centers, increasing demand for accessories/consumables in home healthcare settings, and the recurrent need for infusion pump accessories/consumables.

In the same year, the multi-channel infusion pumps segment is projected to dominate the infusion pumps segment based on channel. This supremacy is driven by factors like the capability of multi-channel pumps to administer multiple fluids simultaneously without continuous monitoring, technological advancements in multi-channel infusion pumps, and the reduced effort required by healthcare professionals for continuous medication monitoring.

In terms of applications, the oncology segment is expected to hold the largest share of the infusion pumps segment in 2023. Factors such as the surge in cancer patients, the rising number of patients undergoing chemotherapy, and the convenience of using portable chemotherapy infusion pumps contribute to the segment's preeminence.

Moreover, the hospitals & clinics segment is forecasted to account for the largest share of the infusion pumps segment based on end users in 2023. This dominance is attributed to factors like the escalating hospital admissions of patients with chronic diseases and the increasing adoption of infusion pumps due to their manifold advantages over manual IV setups. Additionally, the adoption of infusion pumps surged during the COVID-19 pandemic, as these pumps facilitated automatic, reliable, and contact-free dosing for patients with severe cases.

Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4973
Geographic Review

This comprehensive research report provides a detailed analysis of major geographies, encompassing North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.

In 2023, North America is expected to capture the largest share of the infusion pumps market, followed by Europe and Asia-Pacific. Additionally, within North America, the U.S. is anticipated to emerge as the largest market shareholder. This growth is primarily fueled by factors such as the widespread adoption of advanced technologies, high health literacy among the population, particularly regarding the adoption of advanced portable infusion pumps, and substantial government investments in the healthcare sector.

About Meticulous Research®

Meticulous Research® is a leading provider of premium market research reports serving a diverse clientele worldwide. With a steadfast commitment to delivering meticulously crafted, high-quality intelligence, we empower businesses to make informed decisions and capitalize on emerging opportunities.

Contact Information:

Meticulous Research®
Email: [email protected]
Phone: +1-646-781-8004
Website: www.meticulousresearch.com